Viewing StudyNCT00459069



Ignite Creation Date: 2024-05-05 @ 5:27 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00459069
Status: COMPLETED
Last Update Posted: 2010-01-12
First Post: 2007-04-10

Brief Title: The Use of Dendritic CellTumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma
Sponsor: Beth Israel Deaconess Medical Center
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 03-240
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Beth Israel Deaconess Medical Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: David Avigan MD
Old Organization: Beth Israel Deaconess Medical Center

Collaborators

Name Class
Brigham and Womens Hospital OTHER
Dana-Farber Cancer Institute OTHER